Evidence map›Paper›PMID 26039899›Full record

ArticleJournal of proteome research2015

A Comparison of Methods To Enhance Protein Detection of Lipoproteins by Mass Spectrometry.

Anna Heink, W Sean Davidson, Debi K Swertfeger, L Jason Lu, Amy S Shah

Abstract readComparative Study
In one paragraph

Article in Journal of proteome research, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed.

  1. Article
  2. Review
  3. Deepening our understanding of HDL proteome.Expert review of proteomics · 2019
    Review
  4. Article
  5. Article
  6. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Anna Heink
W Sean Davidson§Center for Lipid and Arteriosclerosis Science, Department of Pathology and Laboratory Medicine, University of Cincinnati, 2120 East Galbraith Road, Cincinnati, Ohio 45237-0507, United States.
Debi K Swertfeger
L Jason Lu
Amy S Shah

Funding

LCenter for Clinical and Translational Science and TrainingUL1TR001425 · NCATS · UNIVERSITY OF CINCINNATI · PI HEUBI, JAMES E., KISSELA, BRETT M · 2015 to 2024
$37.5M
Cincinnati Center for Clinical and Translational Sciences and TrainingUL1TR000077 · NCATS · UNIVERSITY OF CINCINNATI · PI HEUBI, JAMES E., TSEVAT, JOEL · 2012 to 2014
$9.9M
Apolipoprotein A-I structure in high density lipoproteinsR01HL067093 · NHLBI · UNIVERSITY OF CINCINNATI · PI DAVIDSON, W SEAN · 2002 to 2016
$4.3M
A Network-based Approach to Associate HDL Subspeciation with FunctionR01HL111829 · NHLBI · CINCINNATI CHILDRENS HOSP MED CTR · PI LU, LONG · 2012 to 2016
$2.6M
APOLIPOPROTEIN-MEDIATED CHOLESTEROL EFFLUXR01HL062542 · NHLBI · UNIVERSITY OF CINCINNATI · PI DAVIDSON, W SEAN · 1999 to 2008
$2.2M
Understanding the Role of HDL Subspecies in Adolescents with Type 2 DiabetesK23HL118132 · NHLBI · CINCINNATI CHILDRENS HOSP MED CTR · PI SHAH, AMY SANGHAVI · 2014 to 2018
$855k
The molecular basis for high density lipoprotein heterogeneityR21HL104136 · NHLBI · UNIVERSITY OF CINCINNATI · PI DAVIDSON, W SEAN · 2010 to 2011
$440k
Enhanced proteomics capabilities for quantitation of proteins with a triple quadS10RR027015 · NCRR · UNIVERSITY OF CINCINNATI · PI GREIS, KENNETH DONALD · 2010 to 2010
$426k
NCATS NIH HHS UL1 TR000077NCATS NIH HHS UL1 TR001425NCRR NIH HHS S10 RR027015NCRR NIH HHS S10 RR027015-01NHLBI NIH HHS K23 HL118132NHLBI NIH HHS K23HL118132NHLBI NIH HHS R01 HL062542NHLBI NIH HHS R01 HL067093NHLBI NIH HHS R01HL104136NHLBI NIH HHS R01 HL111829NHLBI NIH HHS R01HL111829NHLBI NIH HHS R01HL67093NHLBI NIH HHS R21 HL104136
6 · The paper itself

Abstract

We sought to develop a new method to more efficiently analyze lipid-bound proteins by mass spectrometry using a combination of a lipid removal agent (LRA) that selectively targets lipid-bound proteins and a mass spectrometry compatible detergent, anionic acid labile surfactant (AALS), that is capable of eluting proteins off the LRA. This method was compared to established methods that use the lipid removal agent alone and straight proteomic analysis of human plasma after organic solvent delipidation (OSD). Plasma from healthy individuals was separated by gel filtration chromatography and prepared for mass spectrometry analysis by each of the described methods. The addition of AALS to LRA increased the overall number of proteins detected in both the high and low density lipoprotein size range, the number of peptide counts for each protein, and the overall sequence coverage. Organic solvent delipidation detected the most proteins, though with some decrease in overall protein detection and sequence coverage due to the presence of nonlipid-bound proteins. The use of LRA allows for selection and analysis of lipid-bound proteins. The addition of a mass spectrometry compatible detergent improved detection of lipid-bound proteins from human plasma using LRA.

Indexed as

Chromatography, GelHumansLipoproteinsMaleSurface-Active AgentsTandem Mass SpectrometryLipoproteinsSurface-Active Agentsdetergentslipidslipoproteinsmass spectrometrysurfactant

Identifiers

PMID26039899
PMCPMC4714602

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.